Pure Global

BD Difco™ Haemophilus Influenzae Antiserum Type b - HSA Registration DE0509148

Access comprehensive regulatory information for BD Difco™ Haemophilus Influenzae Antiserum Type b in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0509148 and owned by Becton, Dickinson and Company. The device was registered on April 09, 2024.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free Database
Powered by Pure Global AI
HSA Official Data
CLASS B IVD
DE0509148
BD Difco™ Haemophilus Influenzae Antiserum Type b
HSA Registration Number: DE0509148
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Description

BD Difco™ Haemophilus Influenzae Antisera are recommended for use in slide agglutination tests for serotyping Haemophilus influenzae.

Device Classification
Device Class
CLASS B IVD
Medical Speciality Area
Microbiology
Registration Information
Registration Number
DE0509148
Registration Date
April 09, 2024
Change Notification Approval Date
February 17, 2025
Retention Due Date
April 08, 2026
Product Owner
Short Name
Becton, Dickinson and Company
Address
7 Loveton Circle, Sparks, Maryland, 21152, UNITED STATES
Registrant
Address
10 COLLYER QUAY, OCEAN FINANCIAL CENTRE, #10-01, SINGAPORE 049315
Importer
Address
10 COLLYER QUAY, OCEAN FINANCIAL CENTRE, #10-01, SINGAPORE 049315
Model Information
Model Name(s)
BD Difco™ Haemophilus Influenzae Antiserum Type b
Model Identifier(s)
222361